| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aktis Oncology, Inc. | President and CEO, Director | Common Stock | 91,998 | 08 Jan 2026 | Direct | ||
| iTeos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 17,538 | 09 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 08 Jan 2026 | 0 | $0 | 3 | President and CEO, Director | 08 Jan 2026, 21:05 |
| ITOS | iTeos Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 19:56 |
| ITOS | iTeos Therapeutics, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 20:18 |